These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 33217868)

  • 1. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.
    Ji P; Zhu J; Zhong Z; Li H; Pang J; Li B; Zhang J
    Medicine (Baltimore); 2020 Nov; 99(47):e23315. PubMed ID: 33217868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of severe cases with COVID-19: a meta-analysis.
    Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
    Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.
    Henry BM; Benoit SW; de Oliveira MHS; Hsieh WC; Benoit J; Ballout RA; Plebani M; Lippi G
    Clin Biochem; 2020 Jul; 81():1-8. PubMed ID: 32473151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
    Borges do Nascimento IJ; von Groote TC; O'Mathúna DP; Abdulazeem HM; Henderson C; Jayarajah U; Weerasekara I; Poklepovic Pericic T; Klapproth HEG; Puljak L; Cacic N; Zakarija-Grkovic I; Guimarães SMM; Atallah AN; Bragazzi NL; Marcolino MS; Marusic A; Jeroncic A;
    PLoS One; 2020; 15(9):e0239235. PubMed ID: 32941548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of inflammatory markers with the severity of COVID-19: A meta-analysis.
    Zeng F; Huang Y; Guo Y; Yin M; Chen X; Xiao L; Deng G
    Int J Infect Dis; 2020 Jul; 96():467-474. PubMed ID: 32425643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory findings of COVID-19: a systematic review and meta-analysis.
    Zhang ZL; Hou YL; Li DT; Li FZ
    Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we predict the severity of coronavirus disease 2019 with a routine blood test?
    Zeng F; Li L; Zeng J; Deng Y; Huang H; Chen B; Deng G
    Pol Arch Intern Med; 2020 May; 130(5):400-406. PubMed ID: 32356642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 16. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus.
    Renieris G; Katrini K; Damoulari C; Akinosoglou K; Psarrakis C; Kyriakopoulou M; Dimopoulos G; Lada M; Koufargyris P; Giamarellos-Bourboulis EJ
    Shock; 2020 Nov; 54(5):633-637. PubMed ID: 32433216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
    An PJ; Zhu YZ; Yang LP
    Pharmacol Res; 2020 Sep; 159():104946. PubMed ID: 32450346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
    Zhao K; Li R; Wu X; Zhao Y; Wang T; Zheng Z; Zeng S; Ding X; Nie H
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2279-2287. PubMed ID: 32651736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.